This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • An Open-Label, Multi-Centre, Extension Study, eval...
Clinical trial

An Open-Label, Multi-Centre, Extension Study, evaluating the Long-Term Safety and Tolerability of Different Three-Month Degarelix Dosing Regimens, 240 mg (40 mg/mL), 240 mg (60 mg/mL), in Patients with Prostate Cancer.

Read time: 1 mins
Last updated:24th Jan 2006
To evaluate the safety and tolerability of different dosing regimens
Category Value
Study start date 2006-01-24

View full details